(NP (NP Expression/NN) (PP of/IN (NP-COOD (NP c-fos/NN) ,/, (NP c-jun/NN) and/CC (NP jun/NN B/NN))) (PP in/IN (NP (NP peripheral/JJ blood/NN lymphocytes/NNS) (PP from/IN (NP (ADJP-COOD (ADJP young/JJ) and/CC (ADJP elderly/JJ)) adults/NNS)))) ./.)
(S (NP-SBJ-8 (NP The/DT expression/NN) (PP of/IN (NP (NP-COOD (NP c-fos/NN) ,/, (NP c-jun/NN) and/CC (NP jun/NN B/NN)) proto-oncogenes/NNS))) (VP was/VBD (VP studied/VBN (NP *-8/-NONE-) (PP in/IN (NP (NP (ADJP (NP (NP phytohemagglutinin/NN) (PRN -LRB-/-LRB- (NP PHA/NN) -RRB-/-RRB-)) activated/VBN) (NP (NP peripheral/JJ blood/NN lymphocytes/NNS) (PRN -LRB-/-LRB- (NP PBL/NN) -RRB-/-RRB-))) (PP from/IN (NP (ADJP-COOD (ADJP young/JJ) and/CC (ADJP aged/JJ)) humans/NNS)))))) ./.)
(S (NP-SBJ (NP Specific/JJ mRNAs/NNS) (PP for/IN (NP-COOD (NP c-fos/NN) and/CC (NP c-jun/NN)))) (VP-COOD (VP were/VBD (ADJP-PRD detectable/JJ) (PP-TMP within/IN (NP (NP 30/CD min/NN) (PP-TMP after/IN (NP cell/NN activation/NN))))) and/CC (VP reached/VBD (NP maximal/JJ levels/NNS) (PP-TMP within/IN (NP 2/CD h/NN)))) ./.)
(S (NP-SBJ (NP-COOD Both/CC (NP c-fos/NN) and/CC (NP jun/NN B/NN)) mRNAs/NNS) (VP decreased/VBD (PP to/TO (NP pre-activation/NN levels/NNS)) (PP-TMP within/IN (NP 6/CD h/NN)) ,/, (SBAR while/IN (S (NP-SBJ c-jun/NN mRNA/NN) (VP remained/VBD (ADJP-PRD elevated/JJ))))) ./.)
(S (PP In/IN (NP PHA-activated/JJ PBL/NN)) ,/, (NP-SBJ-9 no/DT age-related/JJ differences/NNS) (VP were/VBD (VP observed/VBN (NP *-9/-NONE-) (PP in/IN (NP (NP-COOD (NP c-fos/NN) or/CC (NP jun/NN B/NN)) mRNA/NN expression/NN)))) ./.)
(S (ADVP However/RB) ,/, (NP-SBJ c-jun/NN mRNA/NN levels/NNS) (VP decreased/VBD (ADVP (ADVP significantly/RB) (PRN -LRB-/-LRB- (FRAG (NP (NP-COOD (NP (QP 1.73/CD +\/-/CC 0.08/CD) (NP *RNR*-10/-NONE-)) vs./CC (NP (QP 1.16/CD +\/-/CC 0.09/CD) (NP *RNR*-10/-NONE-))) (NP-10 arbitrary/JJ units/NNS))) ,/, (S (NP-SBJ P/NN) (VP &lt;/VBG (NP 0.01/CD))) ,/, (FRAG (ADJP-COOD (ADJP young/JJ) vs./CC (ADJP old/JJ))) -RRB-/-RRB-)) (PP in/IN (NP PBL/NN) (PP from/IN (NP elderly/JJ individuals/NNS)) (VP activated/VBN (NP */-NONE-) (PP with/IN (NP PHA/NN))))) ./.)
(S (SBAR-PRP Because/IN (S (NP-SBJ previous/JJ work/NN) (VP has/VBZ (VP demonstrated/VBN (SBAR that/IN (S (NP-SBJ-11 (NP T/NN cells/NNS) (PP from/IN (NP elderly/JJ individuals/NNS))) (VP may/MD (VP display/VB (NP normal/JJ proliferative/JJ responses/NNS) (SBAR-TMP (WHADVP-12 when/WRB) (S (NP-SBJ-13 *-11/-NONE-) (VP activated/VBN (NP *-13/-NONE-) (PP via/IN (NP the/DT anti-CD2/JJ pathway/NN)) (ADVP *T*-12/-NONE-)))))))))))) ,/, (NP-SBJ-14 (NP-COOD (NP c-jun/NN) and/CC (NP jun/NN B/NN)) mRNA/NN expression/NN) (VP was/VBD (ADVP also/RB) (VP studied/VBN (NP *-14/-NONE-) (PP in/IN (NP anti-CD2-activated/JJ purified/VBN T/NN cells/NNS)))) ./.)
(S (NP-SBJ-15 No/DT age-related/JJ differences/NNS) (VP were/VBD (VP found/VBN (NP *-15/-NONE-) (PP in/IN (NP (NP the/DT expression/NN) (PP of/IN (NP (NP either/DT) (PP of/IN (NP these/DT two/CD proto-oncogenes/NNS)))) (PP by/IN (NP anti-CD2/NN activated/JJ T/NN cells/NNS)))))) ./.)
(S (NP-SBJ These/DT results/NNS) (VP suggest/VBP (SBAR that/IN (S (NP-SBJ (NP-COOD (NP the/DT decreased/VBN IL-2/NN production/NN) and/CC (NP proliferative/JJ response/NN)) (VP displayed/VBN (NP */-NONE-) (PP by/IN (NP (NP PHA-activated/JJ PBL/NN) (PP from/IN (NP elderly/JJ adults/NNS)))))) (VP may/MD (VP be/VB (ADJP-PRD related/JJ (PP to/TO (NP (NP age-related/JJ changes/NNS) (PP-COOD (PP in/IN (NP c-jun/NN mRNA/NN expression/NN)) and/CC (PP in/IN (NP (NP the/DT ratio/NN) (PP of/IN (NP c-fos/NN (NP *RNR*-17/-NONE-))) (PP to/TO (NP c-jun/NN (NP *RNR*-17/-NONE-)) (NP-17 mRNA/NN))))))))))))) ./.)
